Skip to main content

Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast.

  • BofA Securities Health Care Conference, Las Vegas

    Fireside chat on Wednesday, May 15, 2024 at 4:40 p.m. ET

The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.05
-2.59 (-1.23%)
AAPL  272.74
-1.49 (-0.54%)
AMD  203.61
-7.25 (-3.44%)
BAC  52.38
+0.69 (1.33%)
GOOG  307.78
-5.25 (-1.68%)
META  657.62
+3.93 (0.60%)
MSFT  401.85
+1.25 (0.31%)
NVDA  185.45
-10.11 (-5.17%)
ORCL  149.68
+1.79 (1.21%)
TSLA  408.89
-8.51 (-2.04%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.